Christian S Schade's Net Worth
$7.21 Million
Who is Christian S Schade?
Christian S Schade has an estimated net worth of $7.21 Million. This is based on reported shares across multiple companies, which include Omthera Pharmaceuticals, Inc., NRG ENERGY, INC., INTEGRA LIFESCIENCES HOLDINGS CORP, Aprea Therapeutics, Inc., Omega Therapeutics, Inc., and MEDAREX INC.
SEC CIK
Christian S Schade's CIK is 0001214496
Past Insider Trading and Trends
2003 was Christian S Schade's most active year for acquiring shares with 26 total transactions. Christian S Schade's most active month to acquire stocks was the month of August. 2009 was Christian S Schade's most active year for disposing of shares, totalling 14 transactions. Christian S Schade's most active month to dispose stocks was the month of August. 2013 saw Christian S Schade paying a total of $657,887.36 for 381,040 shares, this is the most they've acquired in one year. In 2009 Christian S Schade cashed out on 1,651,464 shares for a total of $26,423,424.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Omthera Pharmaceuticals, Inc. No price found
Executive VP and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -25.60K |
$2.08 | $657,887.36 |
0
|
Jul 16 - Jul 18
| |||
Form 4
|
∞
| 25.6K |
—
|
—
| 25.6K |
Apr 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NRG ENERGY, INC. (NRG) Snapshot price: $76.51
Exec VP & Chief Financial Ofc
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -12.27% | -4.88K |
$21.60 | -$105,494.40 | 34.92K |
Mar 29
| |||
Form 4
| +74.56% | 17K |
—
|
—
| 39.8K |
Jan 3
| |||
Form 4
|
∞
| 22.8K |
—
|
—
| 22.8K |
Mar 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Snapshot price: $18.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +15.87% | 8.7K |
—
|
—
| 63.5K |
May 9
| |||
Form 4
| +8.91% | 4.49K |
—
|
—
| 54.81K |
May 12
| |||
Form 4
| +10.35% | 4.72K |
—
|
—
| 50.32K |
May 13
| |||
Form 4
| +8.12% | 3.43K |
—
|
—
| 45.6K |
May 14
| |||
Form 4
| +13.48% | 5.01K |
—
|
—
| 42.17K |
May 13
| |||
Form 4
| +13.89% | 4.53K |
—
|
—
| 37.16K |
May 16
| |||
Form 4
|
—
|
0
|
$36.77 | -$463,400.08 | 32.63K |
May 10
| |||
Form 4
| +9.99% | 2.96K |
—
|
—
| 32.63K |
May 17
| |||
Form 4
|
—
|
0
|
$35.47 | -$545,203.73 | 29.67K |
Mar 5
| |||
Form 4
| +13.57% | 3.54K |
—
|
—
| 29.67K |
May 23
| |||
Form 4
| +21.84% | 2.34K |
—
|
—
| 13.06K |
May 24
| |||
Form 4
|
—
|
0
|
$55.82 | -$228,678.04 | 10.72K |
May 3
| |||
Form 4
| +28.46% | 2.3K |
—
|
—
| 10.36K |
May 22
| |||
Form 4
| -45.21% | -6.66K |
—
|
—
| 8.07K |
May 14
| |||
Form 4
| +23.71% | 2.82K |
—
|
—
| 14.72K |
May 20
| |||
Form 4
|
—
|
0
|
$35.94 | -$166,772.25 | 11.9K |
Feb 28
| |||
Form 4
| +40.40% | 3.42K |
—
|
—
| 11.9K |
May 22
| |||
Form 4
| +41.83% | 2.5K |
—
|
—
| 8.48K |
May 17
| |||
Form 4
| +32.82% | 1.48K |
—
|
—
| 5.98K |
May 17
| |||
Form 4
| +46.96% | 1.44K |
—
|
—
| 4.5K |
May 19
| |||
Form 4
| +65.25% | 1.21K |
—
|
—
| 3.06K |
May 20
| |||
Form 4/A
| +51.51% | 630 |
—
|
—
| 1.85K |
Aug 19
| |||
Form 4
| +50.37% | 616 |
$48.68 | $29,986.88 | 1.84K |
Aug 18 - Aug 19
| |||
Form 4
| +83.63% | 557 |
—
|
—
| 1.22K |
Jun 12
| |||
Form 4
|
∞
| 666 |
—
|
—
| 666 |
May 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aprea Therapeutics, Inc. (APRE) Snapshot price: $3.48
Chairman & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +14.28% | 32.4K |
—
|
—
| 259.25K |
Jul 28
| |||
Form 4
| -22.48% | -65.77K |
$0.81 | -$52,944.85 | 226.85K |
Jun 3
| |||
Form 4
| +14.70% | 37.5K |
$0.64 | $24,123.75 | 292.62K |
May 18
| |||
Form 4
| +64.57% | 100.1K |
—
|
—
| 255.12K |
Mar 10
| |||
Form 4
| -12.25% | -21.64K |
$1.74 | -$37,660.56 | 155.02K |
Feb 25
| |||
Form 4
| +187.39% | 165.5K |
—
|
—
| 253.82K |
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 24
| |||
Form 4
|
∞
| 11K |
$15.00 | $165,000.00 | 11K |
Oct 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Omega Therapeutics, Inc. (OMGA) Snapshot price: $1.22
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||